GRP-041 Collection and Analysis of Adverse Effects and Co-Medications for Outpatients Receiving Boceprevir- Or Telaprevir-Based Treatment for Chronic Hepatitis C

European Journal of Hospital Pharmacy: Science and Practice - Belgium
doi 10.1136/ejhpharm-2013-000276.041
Full Text
Abstract

Available in full text

Categories
Pharmacy
Date
Authors
Publisher

BMJ

Related search

Boceprevir and Telaprevir for the Treatment of Chronic Hepatitis C: Safety Management in Clinical Practice

Liver International
Hepatology
2011English

CPC-107 Pharmacotherapy Follow-Up in Chronic Hepatitis C Patients Treated With Boceprevir or Telaprevir

European Journal of Hospital Pharmacy: Science and Practice
Pharmacy
2013English

Boceprevir in the Treatment of Chronic Hepatitis C Virus Infection

Virus Adaptation and Treatment
VirologyInfectious DiseasesImmunology
2011English

Comparison of Adverse Effects Related to Pegylated Interferon-Based Therapy for Patients With Chronic Hepatitis B and Chronic Hepatitis C in Taiwan

Hepatology International
Hepatology
2010English

The Effect on Gastric Emptying of Telaprevir-Based Triple Therapy for Chronic Hepatitis C Patients

2015English

Telaprevir in a Patient With Chronic Hepatitis C and Cryoglobulinemic Glomerulonephritis

Antiviral Therapy
Infectious DiseasesPharmacology
2013English

New Agents for the Treatment of Hepatitis C Virus &Ndash; Focus on Telaprevir

Virus Adaptation and Treatment
VirologyInfectious DiseasesImmunology
2012English

Historical Treatment of Chronic Hepatitis B and Chronic Hepatitis C.

Gut
Gastroenterology
1993English

Effect of Fibrosis on Adverse Events in Patients With Hepatitis C Treated With Telaprevir

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy